- Home
- MFI vs RDHL Comparison
MFI vs RDHL Comparison
Compare MFI & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFI
- RDHL
- Stock Information
- Founded
- MFI 2002
- RDHL 2009
- Country
- MFI Hong Kong
- RDHL Israel
- Employees
- MFI 34
- RDHL N/A
- Industry
- MFI
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- MFI
- RDHL Health Care
- Exchange
- MFI NYSE
- RDHL Nasdaq
- Market Cap
- MFI 8.2M
- RDHL 3.8M
- IPO Year
- MFI 2024
- RDHL N/A
- Fundamental
- Price
- MFI $0.61
- RDHL $1.98
- Analyst Decision
- MFI
- RDHL
- Analyst Count
- MFI 0
- RDHL 0
- Target Price
- MFI N/A
- RDHL N/A
- AVG Volume (30 Days)
- MFI 87.3K
- RDHL 438.8K
- Earning Date
- MFI 05-20-2025
- RDHL 04-10-2025
- Dividend Yield
- MFI N/A
- RDHL N/A
- EPS Growth
- MFI N/A
- RDHL N/A
- EPS
- MFI N/A
- RDHL N/A
- Revenue
- MFI $3,358,264.00
- RDHL $8,042,999.00
- Revenue This Year
- MFI N/A
- RDHL $381.91
- Revenue Next Year
- MFI N/A
- RDHL N/A
- P/E Ratio
- MFI N/A
- RDHL N/A
- Revenue Growth
- MFI N/A
- RDHL 23.17
- 52 Week Low
- MFI $0.51
- RDHL $1.80
- 52 Week High
- MFI $2.35
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- MFI N/A
- RDHL 37.94
- Support Level
- MFI N/A
- RDHL $1.76
- Resistance Level
- MFI N/A
- RDHL $2.18
- Average True Range (ATR)
- MFI 0.00
- RDHL 0.18
- MACD
- MFI 0.00
- RDHL 0.01
- Stochastic Oscillator
- MFI 0.00
- RDHL 30.56
About MFI MF INTERNATIONAL LIMITED
mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via the internet or a platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.